OneMedNet (ONMD) Research & Development (2022 - 2026)

OneMedNet (ONMD) has reported Research & Development for 5 consecutive years, with $391000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 2.36% year-over-year to $391000.0 in Q2 2026; TTM through Jun 2026 was $1.5 million, a 12.21% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 3.27% from the prior year.
• Research & Development was $391000.0 for Q2 2026 at OneMedNet, up from $378000.0 in the prior quarter.
• Over five years, Research & Development peaked at $880638.0 in Q4 2022 and troughed at $298000.0 in Q3 2024.
• A 5-year average of $445109.2 and a median of $391000.0 in 2026 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slumped 43.34% in 2023 and soared 30.29% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $880638.0 in 2022, then tumbled by 43.34% to $499000.0 in 2023, then tumbled by 31.86% to $340000.0 in 2024, then soared by 30.29% to $443000.0 in 2025, then slipped by 11.74% to $391000.0 in 2026.
• The last three Research & Development figures came in at $391000.0 (Q2 2026), $378000.0 (Q1 2026), and $443000.0 (Q4 2025), per Business Quant data.